Rainer Fuchs

Rainer Fuchs Email and Phone Number

Life Science/IT Consultant, Board Member, Entrepreneur. Retired Chief Information Officer, Harvard Medical School. @ HCEMM / Hungarian Centre of Excellence for Molecular Medicine
szeged, csongrád, hungary
Rainer Fuchs's Location
Sudbury, Massachusetts, United States, United States
About Rainer Fuchs

Strategic prowess with a focus on disciplined delivery that rigorously maximizes the value of information technology for business process and people. An unusually broad experience base, with executive leadership roles at the interface of science and information technology in large and small biotech, big pharma, and academia, including Harvard Medical School, Biogen, Ariad, Aventis, and Glaxo. Startup experience from creating a corporate innovation incubator and launching three drug discovery companies. Proven ability to analyze strategic landscapes and business processes without bias, to explain and justify how information technology can be leveraged to improve operations and create new business opportunities, and to define and execute cost-efficient delivery strategies.Known for his ability to bridge the "language gap" between business and IT by articulating the relevance and impact of complex technology issues such as cyber security, infrastructure requirements, process re-engineering, data mining and visualization in the context of corporate strategic, operational, and financial objectives. Fluent in English and German, with global business experience.

Rainer Fuchs's Current Company Details
HCEMM / Hungarian Centre of Excellence for Molecular Medicine

Hcemm / Hungarian Centre Of Excellence For Molecular Medicine

View
Life Science/IT Consultant, Board Member, Entrepreneur. Retired Chief Information Officer, Harvard Medical School.
szeged, csongrád, hungary
Website:
hcemm.eu
Employees:
18
Rainer Fuchs Work Experience Details
  • Hcemm / Hungarian Centre Of Excellence For Molecular Medicine
    Member Of Scientific Advisory Board
    Hcemm / Hungarian Centre Of Excellence For Molecular Medicine Dec 2020 - Present
    Budapest, Hungary
  • Rockstep Solutions
    Member Of Scientific Advisory Board
    Rockstep Solutions Jul 2017 - Present
    Portland, Maine
  • Bantam Pharmaceutical
    Member Of Scientific Advisory Board
    Bantam Pharmaceutical Aug 2015 - Jun 2022
    Formerly Egenix Pharmaceuticals
  • T1D Exchange
    Advisory Council Member
    T1D Exchange Jan 2015 - Apr 2017
    Boston
  • Orion Bionetworks
    Member Of Strategic Advisory Council
    Orion Bionetworks Apr 2014 - Apr 2017
  • Harvard Medical School
    Chief Information Officer
    Harvard Medical School Jun 2012 - Apr 2017
    Boston
  • Egenix Pharmaceuticals
    Board Of Directors
    Egenix Pharmaceuticals Nov 2012 - Dec 2014
    http://www.egenixinc.com/index.htmOncology startup
  • Massachusetts Life Sciences Center
    Member Of Scientific Advisory Board
    Massachusetts Life Sciences Center Sep 2010 - Dec 2014
  • Provasculon
    Board Of Directors
    Provasculon Mar 2008 - Dec 2013
  • Provasculon
    President
    Provasculon Mar 2008 - Oct 2013
    Cambridge, Ma
    Biotech startup, focused on preclinical research related to SDF-1 and its use as therapeutic in cardiovascular diseases and diabetic wound healing. Founded by Rich Lee and Vincent Segers at MGH, funded by Biogen Idec Innovation Incubator and Partners Innovation Fund. Provasculon was acquired by Mesoblast in 2013.
  • Biogen Idec
    Vice President, R&D Information Technology
    Biogen Idec Apr 2009 - Jun 2012
    Responsible for all information technology solutions for drug discovery, development, clinical, regulatory, drug safety, and quality at Biogen Idec.
  • Biogen Idec
    Executive Director Biogen Idec Innovation Incubator (Bi3)
    Biogen Idec Oct 2006 - Dec 2010
    Conceived of and implemented a novel model for creating early-stage (preclinical) drug discovery companies. BI3 (Biogen Idec Innovation Incubator) provides funding, facilities, scientific and technology support, and operational management to new companies aiming to bring drug candidates into the clinic in a 3 to 4 year time frame (www.biogenidec.com/bi3). Launched three startup companies (Provasculon, Escoublac, Neostasis). President and chairman of Provasculon and Escoublac.
  • Biogen Idec
    Co-Head Discovery Research, Vp
    Biogen Idec Sep 2005 - Oct 2006
    Overseeing Oncology, Molecular Technologies, Informatics and Operations
  • Biogen Idec
    Vice President, Informatics & Operations
    Biogen Idec Apr 2000 - Sep 2005
    Responsibilities include:- Research Informatics (computational drug design, computational biology, laboratory workflow management, decision support systems);- Research Operations (financial and resource management, scientific project and portfolio management);- Corporate Library and Information Services;- Division-wide infrastructure services.
  • Escoublac, Inc.
    President And Board Member
    Escoublac, Inc. Dec 2007 - Dec 2010
  • Aventis
    Global Head, Lead Generation Informatics
    Aventis Jan 2000 - Apr 2000
    Responsible for leadership in drug discovery informatics worldwide.
  • Ariad Pharmaceuticals
    Vice President, Chief Information Officer
    Ariad Pharmaceuticals Jan 1998 - Dec 1999
    Responsible for Scientific Computing (biological, chemical and assay data management and analysis) and Information Technology (MIS) departments.
  • Hoechst-Ariad Genomics Center, Llc
    Director, Bioinformatics
    Hoechst-Ariad Genomics Center, Llc Jan 1998 - Dec 1999
    The Hoechst-ARIAD Genomics Center (HAGC) was a 50/50 joint venture of ARIAD and Hoechst Marion Roussel (HMR) engaged in genomics research, primarily in the fields of osteoporosis and oncology. With the sale of ARIAD’s interest in HAGC to Aventis in 1999, the HAGC became the Aventis Cambridge Genomics Center and the worldwide center of excellence in transcript profiling for Aventis Pharma.Formed and directed Bioinformatics department, responsible for databases, data analysis, tools and methods development, data acquisition, and laboratory information management.
  • Glaxo Wellcome
    Director, Bioinformatics
    Glaxo Wellcome Jun 1994 - Jan 1998
    Created and directed Glaxo’s US Bioinformatics program. The department’s main responsibility was to enable and promote the use of genomics information for target identification and selection by all drug discovery projects, and to address all computational components of Glaxo’s genetics research program, including statistical genetics, physical mapping, high-throughput sequencing, sequence analysis, polymorphism analysis, and mutation detection. Member of Executive Committee in GlaxoWellcome's Genetics Directorate.In 1997, Acting Director for Information Access Technology, responsible for evaluating, developing and deploying advanced technologies for information discovery and knowledge dissemination across R&D and Commercial.
  • European Molecular Biology Laboratory (Embl)
    Staff Scientist
    European Molecular Biology Laboratory (Embl) Aug 1989 - Jun 1994
    Staff Scientist in EMBL Data Library, focused on enhancing contents of and access to EMBL sequence databases. Research in sequence analysis.

Rainer Fuchs Skills

Drug Discovery Biotechnology Bioinformatics Genomics Biopharmaceuticals Lifesciences Informatics R&d Genetics Pharmaceutical Industry Computational Biology Technology Transfer Drug Development Assay Development Microbiology Data Analysis Protein Chemistry Sequence Analysis Biomarker Discovery Proteomics Cell Drug Design Sequencing Lims Cell Culture Data Management Cancer Gmp Laboratory 21 Cfr Part 11 Laboratory Automation Cell Biology Infectious Diseases Purification Validation Fda Pharmacology Neuroscience Cro

Rainer Fuchs Education Details

  • University Of Darmstadt, Germany
    University Of Darmstadt, Germany
    Ph.D.
  • University Of Frankfurt, Germany
    University Of Frankfurt, Germany
    Diplom (M.S.)

Frequently Asked Questions about Rainer Fuchs

What company does Rainer Fuchs work for?

Rainer Fuchs works for Hcemm / Hungarian Centre Of Excellence For Molecular Medicine

What is Rainer Fuchs's role at the current company?

Rainer Fuchs's current role is Life Science/IT Consultant, Board Member, Entrepreneur. Retired Chief Information Officer, Harvard Medical School..

What is Rainer Fuchs's email address?

Rainer Fuchs's email address is ra****@****dec.com

What is Rainer Fuchs's direct phone number?

Rainer Fuchs's direct phone number is +161749*****

What schools did Rainer Fuchs attend?

Rainer Fuchs attended University Of Darmstadt, Germany, University Of Frankfurt, Germany.

What skills is Rainer Fuchs known for?

Rainer Fuchs has skills like Drug Discovery, Biotechnology, Bioinformatics, Genomics, Biopharmaceuticals, Lifesciences, Informatics, R&d, Genetics, Pharmaceutical Industry, Computational Biology, Technology Transfer.

Who are Rainer Fuchs's colleagues?

Rainer Fuchs's colleagues are Ernő Homolya, Sayam Ghosal 🇮🇳 🇭🇺, Attila Gacser, Szilvia Juhász, João C. Sequeira, Flóra Mikola, Abdennour Douida,phd.

Not the Rainer Fuchs you were looking for?

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.